Neutropenia
Methodology & AI Transparency ⓘ
Neutropenia Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code D70.9 in Blood & Anemia, Neutropenia requires individualized anticoagulation or in Neutropenia (D70.9: transfusion care) so specialists can calibrate treatment intensity against Serum Ferritin & in Neutropenia (D70.9: Transferrin Saturation) benchmarks.
- 2 Real-world patient consensus: Diagnostic registry D70.9: Neutropenia is managed within Blood & Anemia.
- 3 Typical cash cost range: Differential triage of Neutropenia (D70.9) utilizes individualized anticoagulation or in Neutropenia (D70.9: transfusion care).
- 4 Top reported side effects / signs: Follow-up benchmark in Neutropenia: maintaining Serum Ferritin & in Neutropenia (D70.9: Transferrin Saturation) within Ferritin 50–150 ng/mL; TSAT 20%–45% (D70.9).
Ask our AI Specialists anything about Neutropenia
What Is Neutropenia?
Cataloged under federal diagnostic code D70.9 in Blood & Anemia, Neutropenia requires individualized anticoagulation or in Neutropenia (D70.9: transfusion care) so specialists can calibrate treatment intensity against Serum Ferritin & in Neutropenia (D70.9: Transferrin Saturation) benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Neutropenia (D70.9) features primary platelet/megakaryocyte dysregulation in Neutropenia (D70.9: or inherited/acquired coagulation). therapeutic stabilization in blood & anemia is verified against Vitamin B12, Folate in Neutropenia (D70.9: & Reticulocyte Count).
Common Symptoms & Clinical Signs
- • Presentation of Neutropenia (D70.9): restless legs, ice in Neutropenia (D70.9: craving)
- • Secondary Neutropenia clinical sign: easy bruising, prolonged in Neutropenia (D70.9: bleeding from minor)
- • Symptom flares in Neutropenia correlating with Serum Ferritin & in Neutropenia (D70.9: Transferrin Saturation) deviation outside Ferritin 50–150 ng/mL; TSAT 20%–45% (D70.9)
- • Functional blood & anemia impact requiring individualized anticoagulation or in Neutropenia (D70.9: transfusion care) evaluation (D70.9)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Neutropenia Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | D70.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anemia, Clotting & Blood Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Ferritin & in Neutropenia (D70.9: Transferrin Saturation) | Ferritin 50–150 ng/mL; TSAT 20%–45% (D70.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Vitamin B12, Folate in Neutropenia (D70.9: & Reticulocyte Count) | B12 > 500 pg/mL; appropriate marrow response (D70.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Platelet Count & in Neutropenia (D70.9: PT/INR / aPTT) | Platelets 150–400 x10^3/uL (D70.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Neutropenia
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Captopril Capoten • RxCUI 308963 | Angiotensin Converting Enzyme Inhibitor | 83% | $0.2284 | $ 6.72 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Neutropenia)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony Efbemalenograstim alfa is effective and safe for significantly decreasing the duration of severe neutropenia and the incidence of febrile neutropenia in breast cancer patients who are receiving TA chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer • 2023-12-16 • Phase III Randomized Trial | N = 122 | 88/100 | PMID 38103088 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of melflufen plus daratumumab and dexamethasone in 12%), thrombocytopenia (50% vs. Haematologica • 2024-03-01 • Phase III Randomized Trial | N = 27 | 82/100 | PMID 37646660 ↗ |
| Can This Approach Help? Inside the Latest Research on Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Antimicrobial therapy in low risk afebrile neutropenic patients can be stopped early. Indian journal of pediatrics • 2021-03-15 • Phase III Randomized Trial | N = 75 | 82/100 | PMID 32537711 ↗ |
| Can This Approach Help? Inside the Latest Research on Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in These findings suggest that LD is not a safe alternative to ND in HSCT patients and patients with AL because of increased infection risk without nutritional or other benefit. Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2026-02-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 41406403 ↗ |
| Can This Approach Help? Inside the Latest Research on Timing of Pegfilgrastim Administration and Pegfilgrastim-Induced Bone Pain : A Administration of pegfilgrastim 72 hours postchemotherapy reduced PIBP compared with 24- and 48-hour administration and did not seem to be associated with higher rates of neutropenia or FN. Annals of internal medicine • 2026-05-15 • Phase III Randomized Trial | N = 159 | 82/100 | PMID 41871353 ↗ |
Neutropenia Patient Community & “People Like Me” Threads
Filter Neutropenia community threads and patient logs by age, biological sex, dosage, and treatment duration.